Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

XELJANZ 5 mg film-coated tablets

Active Ingredient:
tofacitinib citrate
Company:  
Pfizer Limited See contact details
ATC code: 
L04AA29
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials HCP Med Info
{arrow_left}
{arrow_right}

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

{pdf_link}

Xeljanz (tofacitinib) Healthcare Professional Brochure

{healthcare_pro_orange} For Healthcare Professionals
Prescriber brochure to provide guidance on assessments prior to prescribing, management, monitoring and safety considerations related to the Risk Management Plan.
{pdf_link}

Xeljanz (tofacitinib) Initiation Checklist

{healthcare_pro_orange} For Healthcare Professionals
Prescriber Initiation checklist to remind HCPs of the risks associated with the use of tofacitinib and the recommended tests before and during tofacitinib administration and treatment
{pdf_link}

Xeljanz (tofacitinib) Maintenance Checklist

{healthcare_pro_orange} For Healthcare Professionals
Prescriber Maintenance checklist to remind HCPs of the risks associated with the use of tofacitinib and the recommended tests before and during tofacitinib administration and treatment
{pdf_link}

Xeljanz (tofacitinib)Patient Alert Card

Patient alert card to help patients understand the risks associated with XELJANZ, and remind them to seek immediate medical attention if they experience any listed signs and symptoms.

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

Pfizer Limited
Company image
Address
Ramsgate Road, Sandwich, Kent, CT13 9NJ
Telephone
+44 (0)1304 616 161
Medical Information Website
www.pfizermedicalinformation.co.uk
Medical Information Direct Line
+44 (0)1304 616161